Virtu Financial LLC Vyant Bio, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.52 - $0.89 $5,092 - $8,715	-9,793 Reduced 38.24%	15,818 $9,000
Q2 2022 Aug 09, 2022	BUY	$0.62 - $1.37 $15,878 - $35,087	25,611 New	25,611 $23,000
Q1 2022 May 17, 2022	SELL	$0.99 - $1.61 $46,665 - $75,890	-47,137 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.32 - $2.96 $62,220 - $139,525	47,137 New	47,137 $64,000
Q3 2021 Nov 12, 2021	SELL	$2.26 - $3.74 $46,339 - $76,684	-20,504 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$2.88 - $4.81 $53,876 - $89,980	-18,707 Reduced 47.71%	20,504 $77,000
Q1 2021 May 19, 2021	BUY	$2.89 - $8.6 $113,319 - $337,214	39,211 New	39,211 $182,000

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.